Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Hassler

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Neuro-Oncology|May 22, 2012
Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysisPeter Horak, Adelheid Wöhrer, Marco Hassler, et al.
Critical Reviews in Oncology/Hematology|March 18, 2008
MeningiomaChristine Marosi, Marco Hassler, Karl Roessler, et al.
Wiener Klinische Wochenschrift|June 24, 2006
Temozolomide for recurrent or progressive high-grade malignant glioma: results of an Austrian multicenter observational studyMarco Hassler, Michael Micksche, Günther Stockhammer, et al.
Cancers|March 29, 2023
Associations of Age and Sex with the Efficacy of Inpatient Cancer Rehabilitation: Results from a Longitudinal Observational Study Using Electronic Patient-Reported OutcomesJens Lehmann, David Riedl, Alain Nickels, et al.
Radiology and Oncology|August 31, 2012
Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experienceMartina Baur, Matthias Preusser, Maria Piribauer, et al.
Neuro-Oncology|March 1, 2007
Venous thromboembolism and survival in patients with high-grade gliomaRalph Simanek, Rainer Vormittag, Marco Hassler, et al.
Cancer Genetics and Cytogenetics|April 18, 2006
Diversity of cytogenetic and pathohistologic profiles in glioblastomaMarco Hassler, Sonja Seidl, Barbara Fazeny-Doerner, et al.
Anti-Cancer Drugs|October 14, 2005
Recurrent and metastatic clivus chordoma: systemic palliative therapy retards disease progressionKatharina Schönegger, Ellen Gelpi, Daniela Prayer, et al.
Wiener Klinische Wochenschrift|February 24, 2010
Attitudes towards palliative care in primary metastatic cancer: a survey among oncologistsKatharina A Kierner, Verena Gartner, Rupert Bartsch, et al.
Wiener Medizinische Wochenschrift (1946)|January 14, 2016
Cancer rehabilitation in Austria--aspects of Physical Medicine and RehabilitationBruno Maehr, Mohammad Keilani, Christoph Wiltschke, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Neuro-Oncology|May 22, 2012
Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysisPeter Horak, Adelheid Wöhrer, Marco Hassler, et al.
Critical Reviews in Oncology/Hematology|March 18, 2008
MeningiomaChristine Marosi, Marco Hassler, Karl Roessler, et al.
Wiener Klinische Wochenschrift|June 24, 2006
Temozolomide for recurrent or progressive high-grade malignant glioma: results of an Austrian multicenter observational studyMarco Hassler, Michael Micksche, Günther Stockhammer, et al.
Cancers|March 29, 2023
Associations of Age and Sex with the Efficacy of Inpatient Cancer Rehabilitation: Results from a Longitudinal Observational Study Using Electronic Patient-Reported OutcomesJens Lehmann, David Riedl, Alain Nickels, et al.
Radiology and Oncology|August 31, 2012
Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experienceMartina Baur, Matthias Preusser, Maria Piribauer, et al.
Neuro-Oncology|March 1, 2007
Venous thromboembolism and survival in patients with high-grade gliomaRalph Simanek, Rainer Vormittag, Marco Hassler, et al.
Cancer Genetics and Cytogenetics|April 18, 2006
Diversity of cytogenetic and pathohistologic profiles in glioblastomaMarco Hassler, Sonja Seidl, Barbara Fazeny-Doerner, et al.
Anti-Cancer Drugs|October 14, 2005
Recurrent and metastatic clivus chordoma: systemic palliative therapy retards disease progressionKatharina Schönegger, Ellen Gelpi, Daniela Prayer, et al.
Wiener Klinische Wochenschrift|February 24, 2010
Attitudes towards palliative care in primary metastatic cancer: a survey among oncologistsKatharina A Kierner, Verena Gartner, Rupert Bartsch, et al.
Wiener Medizinische Wochenschrift (1946)|January 14, 2016
Cancer rehabilitation in Austria--aspects of Physical Medicine and RehabilitationBruno Maehr, Mohammad Keilani, Christoph Wiltschke, et al.
Pageof 2